Aegisy可回收式腔静脉滤器置入术治疗上腔静脉系统血栓患者的效果

打开文本图片集

Effect of Aegisy Retrievable Vena Cava Filter Implantation in the Treatment of Patients with Superior /ena Cava System Thrombosis/.//Medical Innovation of China， 2025， 22（10）： 062-065

[Abstract]Objective： To investigate the influence of Aegisy retrievable vena cava filter on blood routine indexes and the incidence of pulmonary embolism （PE）in patients with superior vena cava system thrombosis. Method： A total of 90 patients with superior vena cava system thrombosis treated in Zibo Expo High-tech Hospital fromJanuary2021toDecember2023were selectedanddividedinto venacava filter group（n=47）andconventional group （ n =43） according to different treatment methods.The vena cava filter group was treated by Aegisy recyclable vena cava filter implantation.The conventional group only received conventionalanticoagulation and thrombolytic therapy.The platelet count （PLT），hemoglobin （Hb），hematocrit （HCT），thecure rate of thrombosis and the incidence of PE were observed before and after treatment.The success rate， recovery rate and incidence of adverse reactions of filter implantation in thevena cava filter group werecalculated. Result：All47 patients who underwent Aegisy retrievablevena cava filter implantationsuccessullyhadfilterimplantation， with an implantation successrateof 100% ， and only l patient had slight filter displacement after surgery.Before and after treatment， there were no significant differences in PLT， Hb and HCT between the two groups （ Pγ >0.05）. There was no significant difference in the cure rate of thrombosis between the two groups （ P >0.05）. The incidence of PE in vena cava filter group was lower than that in conventional group， the difference was statistically significant （ P <0.05）. Of the 47 patients， 31 underwent filter extraction 2 weeks after surgery，of which28 patients were successfully removed， and thefilter recovery rate was 90.32% （28/31）. Conclusion： Compared with conventional treatment， Aegisy retrievable vena cava filter implantation hasabetter effect on the preventionof PE in patients with superior venacavasystem thrombosis， and has less impact on platelet aggregation and bleeding， posing no threat to patients'liver， kidney and other organs.

肺栓塞（PE）是静脉血栓（DVT）常见的并发症，被誉为高致死性危急重症，对罹患DVT的患者来说具有较大的生命威胁，故而预防PE成为治疗DVT 的关键，临床以下腔DVT多见-2]。（剩余5744字）